• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

finance

Record changed: 2022-07-24

Advertisement

More documents for finance

• [1] F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester....
• [2] Roslin Cell Therapies Ltd. (RoslinCT). (8/4/22). "Press Release: RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO". Edinburgh & Hopkinton, MA....
• [3] Active Biotech AB. (8/4/22). "Press Release: Active Biotech Announces a Rights Issue of approximately SEK 55 Million [Not for release in US, AU, CA, JP, et al.]"....
• [4] Northern Gritstone. (8/3/22). "Press Release: Northern Gritstone Backs Spin Out of Imperagen, a University of Manchester Life Science Business"....
• [5] Eleven Therapeutics. (8/2/22). "Press Release: Eleven Therapeutics Announces $22 Million in Seed Funding. Round Includes $9 Million from the Bill & Melinda Gates Foundation". Tel Aviv & Cambridge....
• [6] Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY....
• [7] Replay Holdings LLC. (7/25/22). "Press Release: Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA". San Diego, CA & London....
• [8] NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea...
• [9] Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo to Acquire Zymergen. Acquisition Is Expected to Accelerate the Development of Ginkgo's Innovative Horizontal Synthetic Biology Platform". Boston, MA & Emeryville, CA....
• [10] Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.